375 related articles for article (PubMed ID: 25421675)
1. Epigenetic inhibitors.
Verma M; Banerjee HN
Methods Mol Biol; 2015; 1238():469-85. PubMed ID: 25421675
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic control of gene expression: Potential implications for cancer treatment.
Perri F; Longo F; Giuliano M; Sabbatino F; Favia G; Ionna F; Addeo R; Della Vittoria Scarpati G; Di Lorenzo G; Pisconti S
Crit Rev Oncol Hematol; 2017 Mar; 111():166-172. PubMed ID: 28259291
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic therapy for solid tumors: from bench science to clinical trials.
Juo YY; Gong XJ; Mishra A; Cui X; Baylin SB; Azad NS; Ahuja N
Epigenomics; 2015; 7(2):215-35. PubMed ID: 25942532
[TBL] [Abstract][Full Text] [Related]
4. DNA demethylating agents and epigenetic therapy of cancer.
Mani S; Herceg Z
Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
6. Dual targeting of epigenetic therapy in cancer.
Hellebrekers DM; Griffioen AW; van Engeland M
Biochim Biophys Acta; 2007 Jan; 1775(1):76-91. PubMed ID: 16930846
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic tools in potential anticancer therapy.
Sebova K; Fridrichova I
Anticancer Drugs; 2010 Jul; 21(6):565-77. PubMed ID: 20436342
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic therapy of cancer with histone deacetylase inhibitors.
Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
[TBL] [Abstract][Full Text] [Related]
9. The failure of epigenetic combination therapy for cancer and what it might be telling us about DNA methylation inhibitors.
Yang AS; Yang BJ
Epigenomics; 2016 Jan; 8(1):9-12. PubMed ID: 26698294
[No Abstract] [Full Text] [Related]
10. Innovative approaches to the clinical development of DNA methylation inhibitors as epigenetic remodeling drugs.
Murgo AJ
Semin Oncol; 2005 Oct; 32(5):458-64. PubMed ID: 16210086
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
12. Epigenome: a new target in cancer therapy.
Giacinti L; Vici P; Lopez M
Clin Ter; 2008; 159(5):347-60. PubMed ID: 18998037
[TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase inhibitors for cancer therapy.
Brueckner B; Kuck D; Lyko F
Cancer J; 2007; 13(1):17-22. PubMed ID: 17464242
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics and cancer treatment.
Kristensen LS; Nielsen HM; Hansen LL
Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
[TBL] [Abstract][Full Text] [Related]
15. Pharmaco-epigenomics: discovering therapeutic approaches and biomarkers for cancer therapy.
Claes B; Buysschaert I; Lambrechts D
Heredity (Edinb); 2010 Jul; 105(1):152-60. PubMed ID: 20389307
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic alterations and cancer: new targets for therapy.
Allen A
IDrugs; 2007 Oct; 10(10):709-12. PubMed ID: 17899489
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
18. Targeting epigenetic abnormalities with histone deacetylase inhibitors.
Conley BA; Wright JJ; Kummar S
Cancer; 2006 Aug; 107(4):832-40. PubMed ID: 16826577
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic drugs take on cancer.
Kaiser J
Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
[No Abstract] [Full Text] [Related]
20. Epigenetic regulation in myelodysplastic syndromes: implications for therapy.
Vigna E; Recchia AG; Madeo A; Gentile M; Bossio S; Mazzone C; Lucia E; Morabito L; Gigliotti V; Stefano LD; Caruso N; Servillo P; Franzese S; Fimognari F; Bisconte MG; Gentile C; Morabito F
Expert Opin Investig Drugs; 2011 Apr; 20(4):465-93. PubMed ID: 21381982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]